DE60009145D1 - Zusammensetzung von ginseng und ginkgo zur verbesserung von kognitivem vermögen - Google Patents

Zusammensetzung von ginseng und ginkgo zur verbesserung von kognitivem vermögen

Info

Publication number
DE60009145D1
DE60009145D1 DE60009145T DE60009145T DE60009145D1 DE 60009145 D1 DE60009145 D1 DE 60009145D1 DE 60009145 T DE60009145 T DE 60009145T DE 60009145 T DE60009145 T DE 60009145T DE 60009145 D1 DE60009145 D1 DE 60009145D1
Authority
DE
Germany
Prior art keywords
ginkgo
ginseng
assets
composition
improve cognitive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60009145T
Other languages
English (en)
Other versions
DE60009145T3 (de
DE60009145T2 (de
Inventor
Orlando Petrini
Andrew Scholey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GINSANA S.A., CH
Original Assignee
Pharmaton SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaton SA filed Critical Pharmaton SA
Application granted granted Critical
Publication of DE60009145D1 publication Critical patent/DE60009145D1/de
Publication of DE60009145T2 publication Critical patent/DE60009145T2/de
Publication of DE60009145T3 publication Critical patent/DE60009145T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60009145T 1999-12-17 2000-12-08 Zusammensetzung von ginseng und ginkgo zur verbesserung von kognitivem vermögen Expired - Lifetime DE60009145T3 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17250099P 1999-12-17 1999-12-17
US172500P 1999-12-17
US20835700P 2000-05-31 2000-05-31
US208357P 2000-05-31
PCT/EP2000/012426 WO2001043753A2 (en) 1999-12-17 2000-12-08 Combination of ginseng and ginkgo to improve cognitive skills

Publications (3)

Publication Number Publication Date
DE60009145D1 true DE60009145D1 (de) 2004-04-22
DE60009145T2 DE60009145T2 (de) 2004-07-29
DE60009145T3 DE60009145T3 (de) 2010-02-25

Family

ID=26868153

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60009145T Expired - Lifetime DE60009145T3 (de) 1999-12-17 2000-12-08 Zusammensetzung von ginseng und ginkgo zur verbesserung von kognitivem vermögen

Country Status (15)

Country Link
US (2) US20020015744A1 (de)
EP (1) EP1242105B3 (de)
JP (1) JP2003517016A (de)
AT (1) ATE261733T1 (de)
AU (1) AU3008301A (de)
BR (1) BR0016471A (de)
CA (1) CA2394012A1 (de)
DE (1) DE60009145T3 (de)
DK (1) DK1242105T5 (de)
ES (1) ES2213641T7 (de)
MX (1) MXPA02005938A (de)
NZ (1) NZ520210A (de)
PT (1) PT1242105E (de)
TR (1) TR200400577T4 (de)
WO (1) WO2001043753A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10213571A1 (de) * 2002-03-26 2003-10-23 Lichtwer Pharma Ag Pflanzenextrakte und deren Anwendung
AU2003267419B2 (en) * 2002-09-28 2009-07-02 Pharmaton S.A. Composition comprising panax ginseng and paullinia cupana extracts
CN1305487C (zh) * 2003-03-28 2007-03-21 北京欧纳尔生物工程技术有限公司 治疗良性前列腺增生症引起排尿障碍的药物组合物及其制法
ATE428312T1 (de) * 2004-01-29 2009-05-15 Indena Spa Verwendung von ginkgokomplexen zur verbesserung von kognitiven leistungen und linderung der mentalen ermüdung
US10105405B2 (en) 2006-06-05 2018-10-23 Keyview Labs, Inc. Compositions and methods for enhancing brain function using acetyl-L-carnitine, huperzine A and ginkgo biloba
US10105406B2 (en) 2006-06-05 2018-10-23 Keyview Labs, Inc. Compositions and methods for enhancing brain function using acetyl-L-carnitine, huperzine A, Ginkgo biloba, and vitamin B complex
DE102008020127A1 (de) 2008-04-22 2009-11-05 Merz Pharma Gmbh & Co. Kgaa Kompartimentspezifische Pflanzenextraktkombination aus Ginkgo biloba- und Ginseng-Extrakt mit Tandemwirkung
US9956241B2 (en) 2009-05-04 2018-05-01 Naturex, S.A. Application of American Ginseng to enhance neurocognitive function
US20100278944A1 (en) * 2009-05-04 2010-11-04 Naturex, S.A. Application of american ginseng to enhance neurocognitive function
JP5546851B2 (ja) 2009-12-21 2014-07-09 ライオン株式会社 貧血改善剤及び貧血改善用組成物
US10201577B2 (en) 2017-02-14 2019-02-12 Keyview Labs, Inc. Compositions and methods for enhancing working and long-term memory support using new combination of ginkgo biloba and panax ginseng and associated components

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083932A (en) * 1997-04-18 2000-07-04 Cv Technologies Inc. Pharmaceutical compositions derived from ginseng and methods of treatment using same

Also Published As

Publication number Publication date
CA2394012A1 (en) 2001-06-21
DK1242105T5 (da) 2009-12-07
US20020015744A1 (en) 2002-02-07
NZ520210A (en) 2004-02-27
DK1242105T3 (da) 2004-05-10
MXPA02005938A (es) 2003-10-14
BR0016471A (pt) 2002-08-20
DE60009145T3 (de) 2010-02-25
EP1242105B3 (de) 2009-08-12
EP1242105A2 (de) 2002-09-25
AU3008301A (en) 2001-06-25
ES2213641T3 (es) 2004-09-01
WO2001043753A2 (en) 2001-06-21
DE60009145T2 (de) 2004-07-29
JP2003517016A (ja) 2003-05-20
US20030064118A1 (en) 2003-04-03
WO2001043753A3 (en) 2002-04-25
EP1242105B1 (de) 2004-03-17
PT1242105E (pt) 2004-06-30
US6773729B2 (en) 2004-08-10
TR200400577T4 (tr) 2004-04-21
ATE261733T1 (de) 2004-04-15
ES2213641T7 (es) 2010-03-31

Similar Documents

Publication Publication Date Title
CA2338091A1 (en) Method of conditioning the skin
ATE262313T1 (de) Kosmetisches mittel enthaltend maulbeerbaumextrakt und retinoide
PT799578E (pt) Preparacao combinada contendo germes enriquecidos com electrolitos
DE60009145D1 (de) Zusammensetzung von ginseng und ginkgo zur verbesserung von kognitivem vermögen
HK1041176A1 (zh) 利用含豐富多酚的葡萄提取液的美容療法的食物補充劑及方法
MXPA02004933A (es) Composiciones cosmeticas conteniendo extracto de garbanzo y retinoides.
AU302242S (en) Flashlight
MY148121A (en) Sesamin / episesamin compositions
IL177118A0 (en) Use of a gingo complexes for the enhancement of cognitive functions and the alleviation of mental fatigue
AU304022S (en) Bottle cap
ATE248528T1 (de) Nahrungsmittel mit biotin und anderen b-vitaminen
AU304530S (en) Chair
AU2003294856A1 (en) Use of von tetrahydrobiopterine derivatives in the treatment and nutrition of patients with amino acid metabolic disorders
HUP0203153A2 (hu) Kombinációs kemoterápia
MXPA05009110A (es) Composiciones coloreadas particuladas y su uso en productos de cuidado personal.
AU303541S (en) Cap
ATE291468T1 (de) Carnitin und huperzin enthaltende zusammensetzungen zur behandlung und vorbeugung von hyperaktivität mit aufmerksamkeitstörungen bei kindern
DE69906680D1 (de) Citronnellyl- und/oder dihydrocitronellyllactate, ihre herstellung und ihre anwendung
ITTO981037A0 (it) Composizione farmaceutica, in particolare di tipo dietetico ad azione metabolica e termogenica utilizzabile nel trattamento del sovrappeso
EP1645270A3 (de) Schmerzlinderung mit endogenen cannabinoiden
AU307336S (en) Biometric apparatus
WO2004017971A8 (de) Verwendung von papaverinartigem vasodilatator und pharmazeutische zusammensetzung
Malloy Korean youth's perception of human rights in the context of school and society
AU300372S (en) Personal care product
AU147108S (en) Pan

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1242105

Country of ref document: EP

Representative=s name: HANS-MICHAEL KOMPTER, DE

R081 Change of applicant/patentee

Ref document number: 1242105

Country of ref document: EP

Owner name: GINSANA S.A., CH

Free format text: FORMER OWNER: PHARMATON S.A., BIOGGIO, CH

Effective date: 20121017

R082 Change of representative

Ref document number: 1242105

Country of ref document: EP

Representative=s name: KOMPTER, HANS-MICHAEL, DIPL.-CHEM. DR.RER.NAT., DE

Effective date: 20121017